Point-of-care diagnostics for ricin exposure.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25892365.
- Also identified by DOI 10.1039/c5lc00178a.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A long-sought milestone in the defense against bioterrorism is the development of rapid, simple, and near-patient assays for diagnostic and theranostic purposes. Here, we present a powerful test based on a host response to a biological weapon agent, namely the ricin toxin. A signature for exposure to ricin was extracted and characterized in mice and then integrated into a plastic microfluidic cartridge. This enabled early diagnosis of exposure to ricin in mice using a drop of whole blood in less than 1 h and 30 min. The cartridge stores the reagents and implements all of the steps of the analysis, including mRNA extraction from a drop of blood, followed by tens of parallel RT-qPCR reactions. The simple and low-cost microfluidic cartridge developed here may find other applications in point-of-care diagnostics.
Medical subject headings
- Biological Warfare Agents
- Lab-On-A-Chip Devices
- Point-of-Care Systems
- Ricin
- Theranostic Nanomedicine